localization in human nasal mucosa, by polymerase chain reaction (PCR) and immunohistochemistry.Human turbinates were obtained after turbinectomy from 6 patients with nasal obstruction refractory to medical therapy. Total RNA was isolated from human nasal mucosa, and CysLT2 receptor mRNA was detected in these tissues by using reverse transcriptase-PCR analysis. To identify the cells expressing CysLT2 receptor protein, double immunostaining was performed using anti-CysLT2 receptor antibody and anti-CD31 (endothelial cell) antibody. Results: Reverse transcriptase-PCR analysis of total nasal RNA demonstrated the expression of CysLT2 receptor mRNA. The immunohistochemical studies revealed that anti-CysLT2 receptor antibody mainly labeled blood vessels.
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2 Laboratory of Human Genetics of Infectious Diseases, Faculté de Médecine Necker-Enfants Malades, Paris, France. Background: Chronic granulomatous disease (CGD) is a rare primary immunodeficiency caused by inborn errors of the phagocyte NADPH oxidase activity. Affected patients display severe, recurrent and multiple infections from the first year of life onwards, in particular caused by various pyogenic bacteria and fungi. Mycobacterial infections have more rarely been reported in these patients. Methods: We examined the clinical features of mycobacterial disease in 59 CGD patients from 52 kindreds in 16 countries of 4 continents. Tuberculosis or BCG adverse reactions were identified by culture, staining, biopsy, polymerase chain reaction (PCR), and/or by a combination of clinical criteria with response to treatment. CGD was confirmed by NBT, DHR, cytochrome C reduction assay, or a combination of these. Genetic diagnosis was achieved by means of immunoblotting, flow cytometry, PCR and automated gene sequencing. Results: We found that mycobacterial infections are fairly common in patients with CGD living in certain regions of the world. Twenty-four patients (45%) had tuberculosis, 43 (80%) presented with adverse effects shortly after Bacille Calmette-Guérin (BCG) vaccination; 12 of the patients (21%) had both tuberculosis infection and BCG adverse reactions. Most patients (93%) had also pyogenic and fungal infections; 7% of them, however, presented solely with mycobacterial disease. Most cases were one-time self-limited localized infections, but recurrence (13 patients, 20%), disseminated disease (18 patients, 30%) and even death (5 patients, 8%) were observed. A recurrent finding was early age of presentation for BCG reaction, with a median of 3 months of age; BCG disease was the first manifestation of immunodeficiency in 60% of these patients. Conclusions: Our study offers compelling evidence for an important susceptibility to mycobacterial diseases in patients with CGD, more easily noticed in countries where tuberculosis is endemic and BCG vaccine mandatory. BCG adverse reactions should raise the suspicion of CGD. Methods: Thirteen patients with XLA were included in the study. PBMC LPS-induced TNF-a, IL-1b, IL-6, and IL-10 production was determined by ELISA and compared with that obtained from matched healthy controls. Cytokine production was correlated with the severity of the mutation, affected domain and clinical characteristics.
Results: In response to LPS, PBMC from XLA patients produced significantly higher amounts of pro-inflammatory cytokines and IL-10 compared with controls and this production is not influenced by the neither severity of mutation or the affected domain. PBMC from patients with a history of more hospital admissions before diagnosis and patients with lower expression of Btk in monocytes produced higher levels of TNF-a and IL-1b, respectively. PBMC from patients with lower IgA levels showed a higher production of TNF-a and IL-1b. Less severe (punctual) mutations in Btk gene were associated with higher IgG levels at diagnosis. Conclusions: Our results demonstrated a predominantly inflammatory response in XLA patients after LPS stimuli and suggest a TLR signaling dysregulation in absence of Btk. This response may be influenced by environmental factors. 
